Designing a Long Acting Erythropoietin by Fusing Three Carboxyl-Terminal Peptides of Human Chorionic Gonadotropin β Subunit to the N-Terminal and C-Terminal Coding Sequence.
about
MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.New treatment approaches in chronic kidney disease-associated anaemia.Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.Strategies to Develop Therapeutic N- and O-Hyperglycosylated Proteins.Molecular Design, Expression and Evaluation of PASylated Human Recombinant Erythropoietin with Enhanced Functional Properties.
P2860
Designing a Long Acting Erythropoietin by Fusing Three Carboxyl-Terminal Peptides of Human Chorionic Gonadotropin β Subunit to the N-Terminal and C-Terminal Coding Sequence.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Designing a Long Acting Erythr ...... nd C-Terminal Coding Sequence.
@en
type
label
Designing a Long Acting Erythr ...... nd C-Terminal Coding Sequence.
@en
prefLabel
Designing a Long Acting Erythr ...... nd C-Terminal Coding Sequence.
@en
P2093
P2860
P356
P1476
Designing a Long Acting Erythr ...... nd C-Terminal Coding Sequence.
@en
P2093
Avri Havron
Fuad Fares
P2860
P304
P356
10.1155/2011/275063
P577
2011-08-21T00:00:00Z